Literature DB >> 10620480

Phyllanthus orbicularis aqueous extract: cytotoxic, genotoxic, and antimutagenic effects in the CHO cell line.

A Sànchez-Lamar1, M Fiore, E Cundari, R Ricordy, R Cozzi, R De Salvia.   

Abstract

The present work evaluates the cytotoxic, genotoxic, and antimutagenic effects of Phyllanthus orbicularis (plant of genus Phyllantus) aqueous extract in Chinese hamster ovary (CHO) cells. P. orbicularis aqueous extracts are used in Cuban traditional medicine for their antiviral activity against Hepatitis B virus and A and B flu virus. The cytotoxicity of the extract was tested by means of colony-forming ability and growth-inhibition assays as well as by measuring the mitotic index. Apoptosis induction and cell-cycle kinetics were analyzed by cytofluorimetric methods. Chromosome aberration assays were performed to study the genotoxic and antimutagenic activity of the extract. Results show that doses of up to 100 microg/ml of the extract did not induce any cytotoxic effects. Cell survival and mitotic index decreased significantly at doses higher than 100 microg/ml as a function of dose as well as of treatment time. Moreover, continuous treatments of up to 18 h induced the appearance of a significant number of apoptotic cells. Following a 3-h exposure to a dose of 750 microg/ml, cells accumulated significantly in G(2)-M phase and remained blocked in G(1-) and G(2)-M phases after several posttreatments in fresh growth medium. The aqueous extract alone did not induce chromosome aberrations but, in combined treatment with H(2)O(2), significantly reduced H(2)O(2)-induced chromosome aberrations. Flow cytometric analysis of DCFH intracellular oxidation showed that the extract decreased the oxidizing power of H(2)O(2.) This ability could possibly explain the extract's antigenotoxic activity. Absence of cytotoxicity at the lower tested doses and the antimutagenic properties of the extract stimulate the interest in studying possible new pharmaceutical uses of P. orbicularis. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10620480     DOI: 10.1006/taap.1999.8814

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  4 in total

1.  A pro-apoptotic 15-kDa protein from Bacopa monnieri activates caspase-3 and downregulates Bcl-2 gene expression in mouse mammary carcinoma cells.

Authors:  Manjula Ishwara Kalyani; Sheela Mysore Lingaraju; Bharathi P Salimath
Journal:  J Nat Med       Date:  2012-04-01       Impact factor: 2.343

2.  Potential of Complementary and Alternative Medicine in Preventive Management of Novel H1N1 Flu (Swine Flu) Pandemic: Thwarting Potential Disasters in the Bud.

Authors:  Rajesh Arora; R Chawla; Rohit Marwah; P Arora; R K Sharma; Vinod Kaushik; R Goel; A Kaur; M Silambarasan; R P Tripathi; J R Bhardwaj
Journal:  Evid Based Complement Alternat Med       Date:  2010-10-13       Impact factor: 2.629

3.  New 4'-substituted benzoyl-β-D glycoside from the fruit pulp of Terminalia belerica with antiplatelet and antioxidant potency.

Authors:  Vaseem Ahmad Ansari; Muhammad Arif; Md Sarfaraj Hussain; Hefazat Hussain Siddiqui; Rakesh Kumar Dixit
Journal:  Integr Med Res       Date:  2016-08-16

4.  Insights into the Phytochemistry of the Cuban Endemic Medicinal Plant Phyllanthus orbicularis: Fideloside, a Novel Bioactive 8-C-glycosyl 2,3-Dihydroflavonol.

Authors:  Antonio Francioso; Katrin Franke; Claudio Villani; Luciana Mosca; Maria D'Erme; Stefan Frischbutter; Wolfgang Brandt; Angel Sanchez-Lamar; Ludger Wessjohann
Journal:  Molecules       Date:  2019-08-06       Impact factor: 4.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.